Cavosonstat
- Generic Name
- Cavosonstat
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C16H10ClNO3
- CAS Number
- 1371587-51-7
- Unique Ingredient Identifier
- O2Z8Q22ZE4
- Background
Cavosonstat is under investigation in clinical trial NCT02589236 (Study of Cavosonstat (N91115) in Patients With CF Homozygous for the F508del-CFTR Mutation).
- Associated Conditions
- -
- Associated Therapies
- -
PrecISE (Precision Interventions for Severe and/or Exacerbation-Prone Asthma) Network Study
- Conditions
- Interventions
- First Posted Date
- 2019-10-17
- Last Posted Date
- 2024-07-11
- Lead Sponsor
- University of North Carolina, Chapel Hill
- Target Recruit Count
- 395
- Registration Number
- NCT04129931
- Locations
- ๐บ๐ธ
Cleveland Clinic, Cleveland, Ohio, United States
๐บ๐ธUniversity of California San Diego: Airway Research & Clinical Trials Center, San Diego, California, United States
๐บ๐ธUniversity of California San Francisco, San Francisco, California, United States
MAD Study Evaluating the Safety, Tolerability, and Pharmacokinetics of Cavosonstat (N91115) in Healthy Subjects (SNO-9)
- First Posted Date
- 2016-10-14
- Last Posted Date
- 2017-01-31
- Lead Sponsor
- Nivalis Therapeutics, Inc.
- Target Recruit Count
- 32
- Registration Number
- NCT02934139
- Locations
- ๐บ๐ธ
DaVita Clinical Research, Lakewood, Colorado, United States
Study of Cavosonstat (N91115) in CF Patients Who Are Heterozygous for F508del-CFTR and a Gating Mutation and Being Treated With Ivacaftor
- First Posted Date
- 2016-03-31
- Last Posted Date
- 2016-11-21
- Lead Sponsor
- Nivalis Therapeutics, Inc.
- Target Recruit Count
- 19
- Registration Number
- NCT02724527
- Locations
- ๐บ๐ธ
Rainbow Babies and Children's Hospital - Case Medical Center, Cleveland, Ohio, United States
๐บ๐ธNationwide Children's Hospital, Columbus, Ohio, United States
๐บ๐ธJohns Hopkins Hospital, Baltimore, Maryland, United States
Study of Cavosonstat (N91115) in Patients With CF Homozygous for the F508del-CFTR Mutation
- First Posted Date
- 2015-10-28
- Last Posted Date
- 2017-01-10
- Lead Sponsor
- Nivalis Therapeutics, Inc.
- Target Recruit Count
- 138
- Registration Number
- NCT02589236
- Locations
- ๐บ๐ธ
Yale University, New Haven, Connecticut, United States
๐บ๐ธMaine Medical Center, Portland, Maine, United States
๐บ๐ธJohns Hopkins Hospital, Baltimore, Maryland, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.